Are there socioeconomic gradients in stage and grade of breast cancer at diagnosis? Cross sectional analysis of UK cancer registry data
BMJ 2004; doi: https://doi.org/10.1136/bmj.38114.679387.AE (Published 02 June 2004) Cite this as: BMJ 2004;:bmj;bmj.38114.679387.AEv1Data supplement
Further information and extra table
Further data on women exposed or not exposed to national screening programme
If our hypothesis that socioeconomic variations in uptake of screening have led to socioeconomic variations in disease progression at diagnosis is correct, we would expect that the effect of socioeconomic position on markers of disease progression at diagnosis would be stronger in those age groups eligible for breast cancer screening. The national breast cancer screening programme invites all women aged 50-74 for triennial mammography. The programme was initiated in 1988. We can therefore assume that women aged 75 or above or less than 50 in 1998-2000 would not have been eligible for breast cancer screening. Those aged between 50 and 74 in 1998-2000 would have been eligible for breast cancer screening at some point. Although not all breast cancers in this second group will have been identified by the breast cancer screening programme, exposure to the programme may increase knowledge and awareness of breast cancer and, therefore, may have some effect beyond the time period when it is actively offered.
The odds of women being diagnosed with advanced stage or high grade of disease according to eligibility for the national breast cancer screening programme are shown in the extra table. As expected, socioeconomic position had a stronger effect on disease progression in those women potentially exposed to breast cancer screening.
Odds ratios with tests for trend of odds of advanced stage or high grade of breast cancer at diagnosis by fifths of Townsend deprivation score (TDS) according to eligibility for national breast cancer screening programme
Advanced stage at diagnosis
High grade at diagnosis
Not eligible for screening*
Eligible for screening†
Not eligible for screening*
Eligible for screening†
TDS fifth
No (%)
Odds ratio (95% CI)
No (%)
Odds ratio (95% CI)
No (%)
Odds ratio (95% CI)
No (%)
Odds ratio (95% CI)
1 (most affluent)
375 (25.5)
1.00
130 (8.7)
1.00
408 (29.4)
1.00
359 (25.9)
1.00
2
436 (26.9)
1.07 (0.91, 1.26)
122 (8.9)
1.02 (0.80, 1.33)
422 (28.0)
0.94 (0.80, 1.10)
316 (24.9)
0.95 (0.80, 1.3)
3
501 (29.1)
1.19 (1.02, 1.40)
147 (10.7)
1.26 (0.98, 1.61)
448 (28.0)
0.94 (0.80, 1.10)
339 (26.7)
1.04 (0.87, 1.23)
4
503 (28.8)
1.18 (1.01, 1.38)
134 (10.6)
1.24 (0.96, 1.59)
430 (26.0)
0.84 (0.72, 0.99)
344 (29.4)
1.19 (1.00, 1.42)
5 (most deprived)
577 (32.7)
1.42 (1.22, 1.65)
193 (14.4)
1.75 (1.38, 2.22)
447 (27.1)
0.90 (0.76, 1.05)
362 (29.7)
1.21 (1.02, 1.43)
Test for trend of odds
c2=21.29, P<0.0001
c2=24.40, P<0.0001
c2=3.18, P=0.074
c2=9.02, P=0.003
*Aged <50 or ³75 at diagnosis.
†Aged 50-74 at diagnosis.
Related articles
- This Week In The BMJ Published: 15 July 2004; BMJ 329 doi:10.1136/bmj.329.7458.0-b
See more
- NHS rolls out fast tracked immunotherapy for advanced endometrial cancerBMJ March 05, 2024, 384 q557; DOI: https://doi.org/10.1136/bmj.q557
- Teledentistry may help in detecting oral cancers in current GP and dentist shortagesBMJ March 01, 2024, 384 q512; DOI: https://doi.org/10.1136/bmj.q512
- UK’s progress on cancer survival has slowed in past decade, figures showBMJ February 02, 2024, 384 q290; DOI: https://doi.org/10.1136/bmj.q290
- NHS rolls out national gene testing to spot cancer risk in Jewish communityBMJ February 02, 2024, 384 q283; DOI: https://doi.org/10.1136/bmj.q283
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- Geographic remoteness, area-level socio-economic disadvantage and advanced breast cancer: a cross-sectional, multilevel study
- Organisational efforts to improve quality while reducing healthcare disparities: the case of breast cancer screening among Arab women in Israel
- Three-dimensional reconstruction of sentinel lymph nodes with metastatic breast cancer indicates three distinct patterns of tumour growth